# CEPHALEXIN
> **ANDA213568** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2026-06-09
## Drug
- **FDA Application Number:** ANDA213568
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CEPHALEXIN
- **Generic name:** CEPHALEXIN
- **Active ingredients:** CEPHALEXIN
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2026-06-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213568)
---
*MORVS · CC0 1.0*